Early detection of preeclampsia using inhibin A and other second-trimester serum markers

Fetal Diagnosis and Therapy

Volumn 29, Issue 4, 2011, Pages 280-286

  Ree, Park Hea ^a   Hahn, Won Bo ^a   Chang, Sung Woon ^a   Jung, Sang Hee ^a   Kang, Jin Hee ^b   Cha, Dong Hyun ^b   Kang, Myung Seo ^c   Huh, Ji Young ^b  

^a Bundang CHA Hospital   (South Korea)

^b CHA University   (South Korea)

^c Department of Laboratory Medicine   (South Korea)

Author keywords

Human chorionic gonadotrophin; Inhibin A; Maternal serum alpha fetoprotein; Preeclampsia; Unconjugated estriol

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; ESTRIOL; INHIBIN A; MATERNAL SERUM ALPHA FETOPROTEIN; UNCLASSIFIED DRUG; UNCONJUGATED ESTRIOL;

ADULT; APGAR SCORE; AREA UNDER THE CURVE; ARTICLE; BIRTH WEIGHT; BLOOD SAMPLING; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN SYNDROME; EARLY DIAGNOSIS; FEMALE; GESTATIONAL AGE; HUMAN; MEDICAL RECORD REVIEW; PARITY; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY;

ADULT; ALPHA-FETOPROTEINS; BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN; ESTRIOL; FEMALE; HUMANS; INHIBINS; LOGISTIC MODELS; ODDS RATIO; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, SECOND; RETROSPECTIVE STUDIES;

EID: 79959323866     PISSN: 10153837     EISSN: 14219964     Source Type: Journal    
DOI: 10.1159/000322742     Document Type: Article

References (26)

1. Redman CW, Sargent IL: Latest advances in understanding preeclampsia. Science 2005; 308:1592-1594. (Pubitemid 40807500)
2. Grill S, Rusterholz C, Zanetti-Dällenbach R, Tercanli S, Holzgreve W, Hahn S, Lapaire O: Potential markers of preeclampsia - a review. Reprod Biol Endocrinol 2009;14:70.
3. Merkatz IR, Nitowski HM, Macri JN, Johnson WE: An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities. Am J Obstet Gynecol 1984;148:886-894. (Pubitemid 14125705)
4. Bogart MH, Pandian MR, Jones OW: Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosomal abnormalities. Prenat Diagn 1987;7:623-630. (Pubitemid 17166878)
5. Yaron Y, Cherry M, Kramer RL, O'Brien JE, Hallak M, Johnson MP, Evans MI: Second-trimester maternal serum marker screening: maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome. Am J Obstet Gynecol 1999;181:968-974. (Pubitemid 29503625)
6. Duric K, Skrablin S, Lesin J, Kalafatic D, Kuvacic I, Suchanek E: Second trimester total human chorionic gonadotropin, alpha-fetoprotein and unconjugated estriol in predicting pregnancy complications other than fetal aneuploidy. Eur J Obstet Gynecol Reprod Biol 2003;110:12-15. (Pubitemid 37025690)
7. Silver HM, Lambert-Messerlian GM, Star JA, Hogan J, Canick JA: Comparison of maternal serum total activin A and inhibin A in normal, preeclamptic, and nonproteinuric gestationally hypertensive pregnancies. Am J Obstet Gynecol 1999;180:1131-1137. (Pubitemid 29259006)
8. Kang JH, Farina A, Park JH, Kim SH, Kim JY, Rizzo N, Elmakky A, Cha DH: Down syndrome biochemical markers and screening for preeclampsia at first and second trimester: correlation with the week of onset and the severity. Prenat Diagn 2008;28:704-709.
9. Janssens AC, Moonesinghe R, Yang Q, Steyerberg EW, van Duijn CM: The impact of genotype frequencies on the clinical validity of genomic profiling for predicting common chronic diseases. Genet Med 2007;9:528-535. (Pubitemid 47282041)
10. Poon LC, Kametas NA, Maiz N, Akolekar R, Nicolaides KH: First-trimester prediction of hypertensive disorders in pregnancy. Hypertension 2009;53:812-818.
11. Sibai BM, Koch MA, Freire S, Pinto e Silva JL, Rudge MV, Martins-Costa S, Bartz J: Serum inhibin A and angiogenic factor levels in pregnancies with previous preeclampsia and/or chronic hypertension: are they useful markers for prediction of subsequent preeclampsia? Am J Obstet Gynecol 2008;199:268.e1-e9.
12. Ying SY: Inhibins, activins, and follistatins: gonadal proteins modulating the secretion of follicle-stimulating hormone. Endocrinol Rev 1988;9:267-293.
13. Qu JP, Vankrieken L, Brulet C, Thomas K: Circulating bioactive inhibin levels during human pregnancy. J Clin Endocrinol Metab 1991;72:862-866. (Pubitemid 21921778)
14. Ledger WL: Measurement of inhibin A and activin A in pregnancy - possible diagnostic applications. Mol Cell Endocrinol 2001; 180: 117-121.
15. Muttukrishna S, George L, Fowler PA, Groome NP, Knight PG: Measurement of serum concentrations of inhibin-A (alpha-beta A dimer) during human pregnancy. Clin Endocrinol (Oxf) 1995;42:391-397.
16. Aquilina J, Barnett A, Thompson O, Harrington K: Second-trimester maternal serum inhibin A concentration as an early marker for preeclampsia. Am J Obstet Gynecol 1999;181:131-136. (Pubitemid 29343343)
17. Muttukrishna S, North RA, Morris J, Schellenberg JC, Taylor RS, Asselin J, Ledger W: Serum inhibin A and activin A are elevated prior to the onset of pre-eclampsia. Hum Reprod 2000;15:1640-1645.
18. Florio P, Ciarmela P, Luisi S, Palumbo MA, Lambert-Messerlian G, Severi FM, Petraglia F: Pre-eclampsia with fetal growth restriction: placental and serum activin A and inhibin A levels. Gynecol Endocrinol 2002; 16: 365-372. (Pubitemid 35398650)
19. Silver HM, Lambert-Messerlian GM, Reis FM, Diblasio AM, Petraglia F, Canick JA: Mechanism of increased maternal serum total activin a and inhibin a in preeclampsia. J Soc Gynecol Investig 2002;9:308-312. (Pubitemid 35292300)
20. Thomas RL, Blakemore KJ: Evaluation of elevations in maternal serum alpha-fetoprotein: a review. Obstet Gynecol Surv 1990; 45: 269-283. (Pubitemid 20217895)
21. Sorensen TK, Williams MA, Zingheim RW, Clement SJ, Hickok DE: Elevated second-trimester human chorionic gonadotropin and subsequent pregnancy-induced hypertension. Am J Obstet Gynecol 1993;169:834-838. (Pubitemid 23317514)
22. Petraglia F, Vaughan J, Vale W: Inhibin and activin modulate the release of gonadotropin- releasing hormone, human chorionic gonadotropin, and progesterone from cultured human placental cells. Proc Natl Acad Sci USA 1989;86:5114-5117. (Pubitemid 19182243)
23. Lieppman RE, Williams MA, Cheng EY, Resta R, Zingheim R, Hickok DE, Luthy DA: An association between elevated levels of human chorionic gonadotropin in the midtrimester and adverse pregnancy outcome. Am J Obstet Gynecol 1993;168:1852-1856.
24. Petraglia F, Vaughan J, Vale W: Steroid hormones modulate the release of immunoreactive gonadotropin-releasing hormone from cultured human placental cells. J Clin Endocrinol Metab 1990;70:1173-1178.
25. Santolaya-Forgas J, Jessup J, Burd LI, Prins GS, Burton BK: Pregnancy outcome in women with low midtrimester maternal serum unconjugated estriol. J Reprod Med 1996;41:87-90. (Pubitemid 26067663)
26. Pergament E, Stein AK, Fiddler M, Cho NH, Kupferminc MJ: Adverse pregnancy outcome after a false-positive screen for Down syndrome using multiple markers. Obstet Gynecol 1995;86:255-258.